Moderna: Seasonally Strong thanks to Vaccine Demand in November
Reading Time: 3 minutes
Moderna is a US biotechnology company headquartered in Cambridge, Massachusetts, that specializes in the development of drugs based on mRNA technology. The company gained recognition through its COVID-19 vaccine, which was one of the first globally approved vaccines of this new generation. Moderna is now working on a wide portfolio of mRNA-based therapies, including vaccines for influenza, RSV, and cancer, as well as programs in rare disease research. The business model relies on a modular platform that accelerates research and production, allowing...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
